Jensen Huang, Nvidia president and CEO (Walid Berrazeg/SOPA Images/Sipa USA/Sipa via AP Images)

Tril­lion-dol­lar part­ner: Re­cur­sion rais­es $50M from Nvidia, stock sky­rock­ets

Re­cur­sion Phar­ma­ceu­ti­cals raised $50 mil­lion from Nvidia via a PIPE that placed the AI biotech square­ly in­to the in­vestor fer­vor sur­round­ing the tech com­pa­ny.

Re­cur­sion said Wednes­day morn­ing it now plans to work with Nvidia on the soft­ware com­pa­ny’s cloud ser­vice that us­es gen­er­a­tive AI for drug dis­cov­ery. Re­cur­sion brings a mas­sive bio­chem­i­cal dataset through which Nvidia’s drug dis­cov­ery foun­da­tion mod­els can be trained.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.